10-K Filing

CARDINAL HEALTH INC CIK: 721371 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000721371-23-000060`
Period End Date	20230630
Filing Date	20230815
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	cah-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 66 Cash Flow Statement 110 Stockholders Equity 40 Comprehensive Income 21

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.72B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.04B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.34B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$10.56B	USD	Point-in-time
Inventories, net	`InventoryNet`	$15.94B	USD	Point-in-time
Inventories, net	`InventoryNet`	$15.64B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.02B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.36B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$144.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.83B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.94B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.46B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$7.63B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.08B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.04B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$953.00M	USD	Point-in-time
Total assets	`Assets`	$43.88B	USD	Point-in-time
Total assets	`Assets`	$44.45B	USD	Point-in-time
Total assets	`Assets`	$43.42B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$29.81B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$580.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$792.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.84B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$3.06B	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	$42.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.55B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.71B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.74B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$3.91B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.65B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$9.30B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued 327 million shares at June 30, 2023 and 2022	`CommonStockValue`	$2.75B	USD	Point-in-time
Authorized755 million shares, Issued 327 million shares at June 30, 2023 and 2022	`CommonStockValue`	$2.81B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-534.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-280.00M	USD	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Common shares in treasury, at cost: 76 million shares and 54 million shares at June 30, 2023 and 2022, respectively	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Common shares in treasury, at cost: 76 million shares and 54 million shares at June 30, 2023 and 2022, respectively	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-151.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-709.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-2.85B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$1.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.42B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.88B	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$162.47B	USD	Annual
Revenue	`Revenues`	$205.01B	USD	Annual
Revenue	`Revenues`	$181.36B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$174.82B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$155.69B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$198.12B	USD	Annual
Gross margin	`GrossProfit`	$6.54B	USD	Annual
Gross margin	`GrossProfit`	$6.78B	USD	Annual
Gross margin	`GrossProfit`	$6.89B	USD	Annual
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.53B	USD	Annual
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.56B	USD	Annual
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.83B	USD	Annual
Restructuring and employee severance	`RestructuringCharges`	$95.00M	USD	Annual
Restructuring and employee severance	`RestructuringCharges`	$114.00M	USD	Annual
Restructuring and employee severance	`RestructuringCharges`	$101.00M	USD	Annual
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$285.00M	USD	Annual
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$324.00M	USD	Annual
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$451.00M	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-2.05B	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-79.00M	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.25B	USD	Annual
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-1.13B	USD	Annual
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$302.00M	USD	Annual
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-109.00M	USD	Annual
Operating earnings/(loss)	`OperatingIncomeLoss`	$727.00M	USD	Annual
Operating earnings/(loss)	`OperatingIncomeLoss`	$472.00M	USD	Annual
Operating earnings/(loss)	`OperatingIncomeLoss`	$-596.00M	USD	Annual
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$4.00M	USD	Annual
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$47.00M	USD	Annual
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-16.00M	USD	Annual
Interest expense, net	`InterestExpense`	$149.00M	USD	Annual
Interest expense, net	`InterestExpense`	$93.00M	USD	Annual
Interest expense, net	`InterestExpense`	$180.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-14.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$-2.00M	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$2.00M	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	Annual
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$638.00M	USD	Annual
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$323.00M	USD	Annual
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-769.00M	USD	Annual
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$376.00M	USD	Annual
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$163.00M	USD	Annual
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-289.00M	USD	Annual
Net earnings	`ProfitLoss`	$612.00M	USD	Annual
Net earnings	`ProfitLoss`	$262.00M	USD	Annual
Net earnings	`ProfitLoss`	$-932.00M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$611.00M	USD	Annual
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-933.00M	USD	Annual
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$261.00M	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-3.35	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$1.00	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$2.09	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-3.35	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$1.00	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$2.08	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	292.00M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	261.00M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	279.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	262.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	294.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	279.00M	shares	Annual

Cash Flow Statement 110 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$612.00M	USD	Annual
Net earnings	`ProfitLoss`	$262.00M	USD	Annual
Net earnings	`ProfitLoss`	$-932.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$783.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$692.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$692.00M	USD	Annual
Impairments and loss on sale of other investments	`GainLossOnSaleOfOtherInvestments`	$-24.00M	USD	Annual
Impairments and loss on sale of other investments	`GainLossOnSaleOfOtherInvestments`	-	USD	Annual
Impairments and loss on sale of other investments	`GainLossOnSaleOfOtherInvestments`	$-7.00M	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-2.05B	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-79.00M	USD	Annual
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.25B	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$-2.00M	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$2.00M	USD	Annual
(Gain)/Loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-14.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$89.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$81.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$96.00M	USD	Annual
Provision for/(benefit from) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$496.00M	USD	Annual
Provision for/(benefit from) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-31.00M	USD	Annual
Provision for/(benefit from) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$7.00M	USD	Annual
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$99.00M	USD	Annual
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$68.00M	USD	Annual
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$65.00M	USD	Annual
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$1.53B	USD	Annual
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$904.00M	USD	Annual
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$947.00M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$340.00M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$1.58B	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$1.07B	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.33B	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.43B	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.72B	USD	Annual
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-293.00M	USD	Annual
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-452.00M	USD	Annual
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$967.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.43B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.84B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.12B	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$400.00M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$387.00M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$481.00M	USD	Annual
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	$923.00M	USD	Annual
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	Annual
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$22.00M	USD	Annual
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.00M	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$31.00M	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$12.00M	USD	Annual
Purchase of other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$78.00M	USD	Annual
Purchase of other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$7.00M	USD	Annual
Purchase of other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$22.00M	USD	Annual
Proceeds from sale of investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$29.00M	USD	Annual
Proceeds from sale of investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$47.00M	USD	Annual
Proceeds from sale of investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$3.00M	USD	Annual
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	$71.00M	USD	Annual
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	-	USD	Annual
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	$29.00M	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-378.00M	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$567.00M	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-454.00M	USD	Annual
Purchase of noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	Annual
Purchase of noncontrolling interests	`PaymentsToMinorityShareholders`	$3.00M	USD	Annual
Purchase of noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	Annual
Proceeds from interest rate swap terminations	`PaymentsForProceedsFromHedgeFinancingActivities`	-	USD	Annual
Proceeds from interest rate swap terminations	`PaymentsForProceedsFromHedgeFinancingActivities`	$-18.00M	USD	Annual
Proceeds from interest rate swap terminations	`PaymentsForProceedsFromHedgeFinancingActivities`	-	USD	Annual
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$885.00M	USD	Annual
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$570.00M	USD	Annual
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$579.00M	USD	Annual
Net tax proceeds/(withholding) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$56.00M	USD	Annual
Net tax proceeds/(withholding) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$8.00M	USD	Annual
Net tax proceeds/(withholding) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-19.00M	USD	Annual
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$525.00M	USD	Annual
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$559.00M	USD	Annual
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$573.00M	USD	Annual
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$200.00M	USD	Annual
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	Annual
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.00B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.05B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.32B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.46B	USD	Annual
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.00M	USD	Annual
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-8.00M	USD	Annual
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-25.00M	USD	Annual
Cash reclassified from/(to) assets held for sale	`CashReclassifiedtoAssetsHeldforSale`	-	USD	Annual
Cash reclassified from/(to) assets held for sale	`CashReclassifiedtoAssetsHeldforSale`	$109.00M	USD	Annual
Cash reclassified from/(to) assets held for sale	`CashReclassifiedtoAssetsHeldforSale`	$-109.00M	USD	Annual
Net increase/(decrease) in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.31B	USD	Annual
Net increase/(decrease) in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-674.00M	USD	Annual
Net increase/(decrease) in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$636.00M	USD	Annual
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.77B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.77B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash payments for interest	`InterestPaidNet`	$203.00M	USD	Annual
Cash payments for interest	`InterestPaidNet`	$153.00M	USD	Annual
Cash payments for interest	`InterestPaidNet`	$182.00M	USD	Annual
Net cash payments/(refunds) for income taxes	`IncomeTaxesPaidNet`	$-766.00M	USD	Annual
Net cash payments/(refunds) for income taxes	`IncomeTaxesPaidNet`	$156.00M	USD	Annual
Net cash payments/(refunds) for income taxes	`IncomeTaxesPaidNet`	$273.00M	USD	Annual

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$611.00M	USD	Annual
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-933.00M	USD	Annual
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$261.00M	USD	Annual
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Net earnings	`ProfitLoss`	$612.00M	USD	Annual
Net earnings	`ProfitLoss`	$262.00M	USD	Annual
Net earnings	`ProfitLoss`	$-932.00M	USD	Annual
Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest	`NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest`	$612.00M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$70.00M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-37.00M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-80.00M	USD	Annual
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$65.00M	USD	Annual
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$55.00M	USD	Annual
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$97.00M	USD	Annual
Share repurchase program activity	`TreasuryStockValueAcquiredCostMethod`	$1.00B	USD	Annual
Share repurchase program activity	`TreasuryStockValueAcquiredCostMethod`	$200.00M	USD	Annual
Share repurchase program activity	`TreasuryStockValueAcquiredCostMethod`	$1.91B	USD	Annual
Dividends declared	`Dividends`	$515.00M	USD	Annual
Dividends declared	`Dividends`	$552.00M	USD	Annual
Dividends declared	`Dividends`	$576.00M	USD	Annual
Other	`StockholdersEquityOther`	$-1.00M	USD	Annual
Other	`StockholdersEquityOther`	$1.00M	USD	Annual
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	`MinorityInterestDecreaseFromRedemptions`	$-3.00M	USD	Annual

Comprehensive Income 21 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$612.00M	USD	Annual
Net earnings	`ProfitLoss`	$262.00M	USD	Annual
Net earnings	`ProfitLoss`	$-932.00M	USD	Annual
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$46.00M	USD	Annual
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-56.00M	USD	Annual
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-35.00M	USD	Annual
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-2.00M	USD	Annual
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-24.00M	USD	Annual
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$24.00M	USD	Annual
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$70.00M	USD	Annual
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-80.00M	USD	Annual
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-37.00M	USD	Annual
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$225.00M	USD	Annual
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$682.00M	USD	Annual
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.01B	USD	Annual
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Net Income (Loss) Attributable to Noncontrolling Interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	Annual
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$681.00M	USD	Annual
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$224.00M	USD	Annual
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-1.01B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.